Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Assist Reprod Genet ; 17(5): 260-3, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10976412

RESUMO

PURPOSE: To compare the efficiency of transvaginal ultrasound-guided functional ovarian cyst aspiration, with conservative management, in the outcome of patients undergoing assisted reproductive technique (ART) (in vitro fertilization or intracytoplasmic sperm injection). These cysts were identified before ovarian stimulation begun and after administration of a midluteal GnRH agonist. METHODS: Fifty nine patients undergoing ART from January 1, 1997 to February 28, 1999, who developed functional ovarian cysts were included. Aspirations of these cysts (n = 14) versus conservative management (observation) (n = 45) were compared. Total number of ovarian follicles developed, number of oocytes retrieved, estradiol levels on the day of human chorionic gonadotropin, fertilization rate, number of good quality embryos transferred, implantation, and clinical pregnancy rate per cycle were evaluated. RESULTS: No statistical differences were observed between the two groups in any of the selected parameters. CONCLUSIONS: Cyst aspiration and conservative management showed similar implantation and pregnancy rates, in patients who develop functional ovarian cysts after pituitary down-regulation following luteal phase gonadotropin-releasing hormone agonist administration. Prospective studies are needed to confirm this trend.


Assuntos
Fertilização in vitro/métodos , Cistos Ovarianos/cirurgia , Cistos Ovarianos/terapia , Ovário/patologia , Indução da Ovulação , Adulto , Gonadotropina Coriônica/sangue , Estradiol/sangue , Feminino , Hormônio Liberador de Gonadotropina/efeitos adversos , Hormônio Liberador de Gonadotropina/análogos & derivados , Hormônio Liberador de Gonadotropina/farmacologia , Humanos , Hormônio Luteinizante/sangue , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Folículo Ovariano/efeitos dos fármacos , Folículo Ovariano/patologia , Folículo Ovariano/cirurgia , Ovário/efeitos dos fármacos , Ovário/cirurgia , Injeções de Esperma Intracitoplásmicas
2.
Fertil Steril ; 73(4): 788-98, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10731542

RESUMO

OBJECTIVE: To reassess endometrial morphological criteria of normality identifying the best morphological and molecular "implantation window" indicators in normal women. DESIGN: Prospective clinical study. SETTING: Assisted reproductive unit. PATIENT(S): Fourteen healthy volunteers. INTERVENTION(S): Blood sampling for LH, E(2), and progesterone (P4) determinations. Daily vaginal ultrasounds. Two endometrial biopsies per volunteer, 7 days apart, during luteal phase. MAIN OUTCOME MEASURE(S): Endometrial dating, pinopodes formation, immunohistochemical determination of integrins (alphavbeta3, alpha4beta1), leukemia inhibitory factor (LIF), interleukin-1 receptor type I (IL-1R tI), mouse ascites Golgi (MAG), the transmembrane mucin (MUC-1), and P4 receptor expression. RESULT(S): In 26 of 28 biopsies observers agreed; in two biopsies there was a discrepancy (difference of 72 hours). With use of LH peak, 24 of 26 samples were in phase, and 2 were 3 days behind. Pinopodes appeared on days 20-21 and persisted through day 28 in small groups or larger areas. beta3 Integrin was highly expressed in luminal and glandular epithelium from day 22 through 28; 48 hours thereafter pinopodes appeared. alpha4 Subunit exhibited luminal epithelium reaction positivity on days 22-23 and glands on days 18-23. LIF and IL-1R tI showed weak, erratic expression. MAG antibodies showed luminal epithelium expression up to day 22 and glands up to day 25. MUC-1 showed positivity during the whole luteal phase. P4 receptors were positive through day 20 and at the end of the luteal phase. CONCLUSION(S): The three most cited markers that frame the window of implantation do not correlate in our material. Pinopodes are present from day 20 on; beta3 and alpha4 integrin subunits indicate a window opening on days 22-23.


Assuntos
Implantação do Embrião , Endométrio/fisiologia , Interleucina-6 , Ciclo Menstrual/fisiologia , Adulto , Endométrio/anatomia & histologia , Estradiol/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Complexo de Golgi/imunologia , Inibidores do Crescimento/metabolismo , Humanos , Imuno-Histoquímica/métodos , Integrina alfa4beta1 , Integrinas/metabolismo , Fator Inibidor de Leucemia , Hormônio Luteinizante/sangue , Linfocinas/metabolismo , Microscopia Eletrônica de Varredura , Mucinas/metabolismo , Estudos Prospectivos , Receptores de Interleucina-1/metabolismo , Receptores Tipo I de Interleucina-1 , Receptores de Retorno de Linfócitos/metabolismo , Receptores de Progesterona/metabolismo , Receptores de Vitronectina/metabolismo , Valores de Referência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA